Received: from IA1PR10MB7264.namprd10.prod.outlook.com (::1) by
 MW4PR10MB5749.namprd10.prod.outlook.com with HTTPS; Sat, 4 Oct 2025 22:53:19
 +0000
Received: from CWLP265CA0319.GBRP265.PROD.OUTLOOK.COM (2603:10a6:401:57::19)
 by IA1PR10MB7264.namprd10.prod.outlook.com (2603:10b6:208:3fe::17) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9182.18; Sat, 4 Oct
 2025 22:53:17 +0000
Received: from AM3PEPF0000A795.eurprd04.prod.outlook.com
 (2603:10a6:401:57:cafe::e6) by CWLP265CA0319.outlook.office365.com
 (2603:10a6:401:57::19) with Microsoft SMTP Server (version=TLS1_3,
 cipher=TLS_AES_256_GCM_SHA384) id 15.20.9182.19 via Frontend Transport; Sat,
 4 Oct 2025 22:53:17 +0000
Authentication-Results: spf=pass (sender IP is 159.183.224.105)
 smtp.mailfrom=em1814.skabeklaterapija.lv; dkim=pass (signature was verified)
 header.d=skabeklaterapija.lv;dmarc=bestguesspass action=none
 header.from=skabeklaterapija.lv;compauth=pass reason=109
Received-SPF: Pass (protection.outlook.com: domain of
 em1814.skabeklaterapija.lv designates 159.183.224.105 as permitted sender)
 receiver=protection.outlook.com; client-ip=159.183.224.105;
 helo=s.wfbtzhsw.outbound-mail.sendgrid.net; pr=C
Received: from s.wfbtzhsw.outbound-mail.sendgrid.net (159.183.224.105) by
 AM3PEPF0000A795.mail.protection.outlook.com (10.167.16.100) with Microsoft
 SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9203.9
 via Frontend Transport; Sat, 4 Oct 2025 22:53:16 +0000
X-IncomingTopHeaderMarker: OriginalChecksum:6552C6CD9331D69B450C0AC7E417CC2A00A2146C080CE4A69EEBED96DCF6E68C;UpperCasedChecksum:D8884DD117695C9E67A11DA017DB232D7F7DD9D5893434A79230DBA0F95680A7;SizeAsReceived:1922;Count:14
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=skabeklaterapija.lv;
	h=from:sender:subject:date:to:cc:content-type:cc:content-type:date:from:
	subject:to;
	s=s1; bh=tEl7xJDXjOgYDoo3ziODMshd0pLb95zlUF1Tafzp7P0=;
	b=eP4YV0+Ased5y13nnaHEaCQ2MOo0aG+QMKpGmZIiaczmDtF85WEIIbFSxggwQszx69Yr
	FeC5W97e56Zu77wQCf/jk/16CUPpMTD9GI50b1xgK0N5ilj1Kwv1EwCg2Y+PTr74UbJMiO
	JDw1COg/Kzy1ohjbKH8rHOWHO2HdnMoXKQDdSBw7mt49GBl49hlwANUSvL7fROTwE7O9lC
	W9oZLLvEuFV9LVmDQDcpjYVxJXWbFa+dLAbX1GmekY2QlfiZnfF6khLC7tag4oAUPcc7jo
	p6ZR8GSOqb2/KjdKIDm+zJ0yDrunZk0pSxbrITiIDp5gBOhfOu6ckykak+E2mk8g==
Received: by recvd-5fb5cd787f-d52gr with SMTP id recvd-5fb5cd787f-d52gr-1-68E1A55C-E
	2025-10-04 22:53:16.17879233 +0000 UTC m=+10563564.105513386
Received: from hoopsel.com (unknown)
	by geopod-ismtpd-14 (SG) with ESMTP
	id lJ-AN3ZQToeKvMdUyLld-g
	for <phishing@pot>;
	Sat, 04 Oct 2025 22:53:16.003 +0000 (UTC)
From: --- Access --- <newsletters.dblwh@skabeklaterapija.lv>
Sender: "--- =?UTF-8?B?QWNjZXNz?= ---"<newsletters.pqljx@skabeklaterapija.lv>
Subject: " Last Notice:       Your                       ID:UGIRA"
Date: Sat, 04 Oct 2025 22:53:16 +0000 (UTC)
Return-Path: bounces+22999152-257f-phishing@pot=hotmail.com@em1814.skabeklaterapija.lv
Message-ID: <KXQFJQOZ048S.N07AFwhtwtT41EXIM@N07AFT41EXIM.eurprd05.prod.outlook.com>
X-SG-EID: =?us-ascii?Q?u001=2Ekl1cFNeRygIIJmqHBmdFLqhH99IbrT3tGBcroMumDC0Kbg8u74rV08jHT?=
 =?us-ascii?Q?5fL2QFazxI7Cvq3iBb=2FmspqyfpB4zavc0ENoC1q?=
 =?us-ascii?Q?HMHKTnUWka4W5ba=2FI5PX5fKYT0m=2F0w+O+z4Xn3P?=
 =?us-ascii?Q?nywguKgI1dy+nHahPHOfaorrcO8U9831zjNPySA?=
 =?us-ascii?Q?J4aCCpzfOgKwy5anPat59Rr3e5exFEanoVBwdal?=
 =?us-ascii?Q?Tm53jVbjU05Xg924EJkpWuLAITWY9ere7eY7qQk?=
 =?us-ascii?Q?Zb6ufdcCX1nTvhyQwREcfI04tQ=3D=3D?=
To: phishing@pot
Cc: phishing@pot
X-Entity-ID: u001.a5rZah+AYYmthWGmKj8b9Q==
Content-Type: multipart/related;boundary="XWDBoundary_HTML_-YYGyxisQvpsttOs"
X-IncomingHeaderCount: 14
X-MS-Exchange-Organization-ExpirationStartTime: 04 Oct 2025 22:53:17.2524
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 9abd46b0-de82-429a-31ca-08de0398cecb
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: AM3PEPF0000A795:EE_|IA1PR10MB7264:EE_|MW4PR10MB5749:EE_
X-MS-Exchange-Organization-AuthSource: AM3PEPF0000A795.eurprd04.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-UserLastLogonTime: 10/4/2025 10:37:11 PM
X-MS-Office365-Filtering-Correlation-Id: 9abd46b0-de82-429a-31ca-08de0398cecb
X-MS-Exchange-EOPDirect: true
X-Sender-IP: 159.183.224.105
X-SID-PRA: NEWSLETTERS.DBLWH@SKABEKLATERAPIJA.LV
X-SID-Result: PASS
X-MS-Exchange-Organization-SCL: 9
X-Microsoft-Antispam: BCL:0;ARA:1444111002|32080799003|9400799040|5101999024|13020799006|970799057|3151999006|4052599003|69000799018|5082599009|20103052909095|58200799018|51300799021|87000799018|9800799015|10300799035|9002599021|6092099016|12005499003|39102599003|84100799003|29080799003|461199028|2700799029|3412199025|4302099013|440099028|34101999003|13082799006|1122599019|18021999003|33101999003|1360799030|1380799030|1370799030|1602099012|17101999012;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 04 Oct 2025 22:53:16.9595
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 9abd46b0-de82-429a-31ca-08de0398cecb
X-MS-Exchange-CrossTenant-Id: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa
X-MS-Exchange-CrossTenant-AuthSource: AM3PEPF0000A795.eurprd04.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-CrossTenant-RMS-PersistedConsumerOrg: 00000000-0000-0000-0000-000000000000
X-MS-Exchange-Transport-CrossTenantHeadersStamped: IA1PR10MB7264
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.2222329
X-MS-Exchange-Processed-By-BccFoldering: 15.20.9182.015
X-Microsoft-Antispam-Mailbox-Delivery:
	ucf:0;jmr:0;ex:0;auth:1;dest:J;OFR:SpamFilterAuthJ;ENG:(5062000311)(920221119095)(90000117)(920221120095)(90005022)(91005020)(91035115)(9050020)(9100341)(944500132)(2008001181)(2008121020)(4810010)(4910033)(10010005)(9610028)(9560006)(10180024)(9320005)(9245025)(120001);RF:JunkEmail;
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0xO1NDTD02
X-Microsoft-Antispam-Message-Info:
	=?iso-8859-1?Q?COwYkXjmuqe5PT83QVTgVnSWxtaLVsP/ihZuTHcogxUwL+vxKwHt5x2lMp?=
 =?iso-8859-1?Q?j2M78e1aunJC2zEcx9YPOCietYYJCUs0Imn+ArUwipXnDWwrcMAFG+ljf3?=
 =?iso-8859-1?Q?heaCPr8nHHPpGm6hOzHJuktosJV+oudUrW+3b+tQgAzQJya0FIaPLCkIA+?=
 =?iso-8859-1?Q?1RXUXK3P9KD1NmTWzYLfg8uzkSEvpnc0XvDOi80UiXlgJ20gSVVQ7Vu7Sh?=
 =?iso-8859-1?Q?soeCi93S/Ah9lDf4WSK/J1AITr5r+qyF0ryY/A94mvVgLxKC+vo4o/F2qu?=
 =?iso-8859-1?Q?Qja3X/gg5eksE7e16zU4aapLNougpeKqeAETdgw3akLw367S+fHQ1yNOrq?=
 =?iso-8859-1?Q?zYp3cp1D5ij9J6GxtkaZkiBpXSFe7YkeP1J4sIoK6orq4PxEHLt/DIDD8z?=
 =?iso-8859-1?Q?uCQBExie3fo4Upw4GNwsBSwADRk+i63afWYp2MApY50tQQraXVZuu6Edfa?=
 =?iso-8859-1?Q?p8ZtccPtyZWjZGPopIX5ASNc+YZYTbJ1suBaaZLuB85KNN2+iAmlZdsE1f?=
 =?iso-8859-1?Q?fL8bWB0TFsLsN02UUNpl7CaQ2+PJJG1e2D0Ck2UBYgdrlYMOIYXwA84S3v?=
 =?iso-8859-1?Q?IH/u8l1yomX85GrPdA3nfnGWqYWAA5cIDI3E4OEierGlI/UgcrU3wJvs3i?=
 =?iso-8859-1?Q?h4xothRAmvtQteUdlN+diGjH4ckbYrA2b99YDr+phw63sL2Etpfn+0AsON?=
 =?iso-8859-1?Q?O1a/5IN5Y76VPz8KxusgE6B1k7D+7cKk+QUNYuvFVmVSy/RQOLRhSUxDIS?=
 =?iso-8859-1?Q?Ff3pX1Kcke5WCXjHvWWsImK/5Mw+PprKlNzuoaK9g61VwHMmoPvvhoTKLd?=
 =?iso-8859-1?Q?TTK09PBxc9q6goitFCoJF4H+QzEbxxpYbqEltauXMxJ+ukOjvU0/DdOD0h?=
 =?iso-8859-1?Q?tWacrNSRx6UG+r9I7k2gZvbA8VkYF7HlkJIhWrN4dpF2wJkR++9CTyo3fB?=
 =?iso-8859-1?Q?+kshGsj/PGSnTVUnu5G5Lo2kw0YF1Fijaj3pK7qmCUmtVIpt4uXfG/EKA0?=
 =?iso-8859-1?Q?XsgWgRlbAjyBq+J+eI+JYHkg38HtxYCycMQRjIRJtV7WBiFXoojldan7M0?=
 =?iso-8859-1?Q?b9Rgi3WHrM1G7rJqjlScvjAQQ/ntvS/GRqrZsudPgWUySjCCRbCXZdWEte?=
 =?iso-8859-1?Q?LZ/uxNQt9cT3If+B85VI260JpLb4ubI+KLXUBqMnqDzSkR5rO0TIeX61t8?=
 =?iso-8859-1?Q?hhmZ0OeBUvC6T1DJYYANtNn3qOec2Aaw6AeAR1YzFwF008AEbbiNRzQnga?=
 =?iso-8859-1?Q?5HUHjQJ46Z8418mMkquGYpu9bnnDy1Nm7DXoP5slBlK6zLocBoX1uN1uDv?=
 =?iso-8859-1?Q?VqQjqo2uVKuSfqlyTMAJbWDiWbaCXmLbFaq5wp4b734cRxUSFGjJhdsPVu?=
 =?iso-8859-1?Q?cCLZdtYhQXDr+E/fLHZN4etln0r9ui51wBz+jB+LBEdIVYYNVD/93tap2y?=
 =?iso-8859-1?Q?QP5+NcRa8QIB6xZqzo6ALNz3P4L4PVvflXV+pZNVKw6Z1OKzyT0GA8GMNy?=
 =?iso-8859-1?Q?35eS0pady3zJYG9fO10ErwfW7Wk6AXNrT36UF7uIH/HhMsz/P/xK8XS3ie?=
 =?iso-8859-1?Q?EYY8J5QNuoGlv1X3zRoNjWr0shW4Ctw9oJ3oJeo07kunxb2M4TTCtcB24d?=
 =?iso-8859-1?Q?eAmX35JEm7RDpUEBxex4f1FcTHVXSlPKdsdD4VmImn155OaYhsxIo/zLre?=
 =?iso-8859-1?Q?UiDFqr62ee5jDtj7zZ5aBUR4EcvBCwsH3IKPJhww8bnglhQMARxqyHqGQZ?=
 =?iso-8859-1?Q?Ef1tHgOIB8/NCZ+mbbKcqYVbJxX0k3G5ozfhW0hBb7EWREyTIYq3t2ueF0?=
 =?iso-8859-1?Q?fiDT7ELgD4HsqYVY6jSYx8BW4ME2j/24lsH0xSvoZ1M0QSdnuDAMzl3r6a?=
 =?iso-8859-1?Q?XHAfM6DcZG7ggTRGAPfywo2hI8hdGgzQWrDMvSoZn9L8drzH+Phz3WH3t2?=
 =?iso-8859-1?Q?xHRFokYbsYoueVuFeLvW39+uR1v7woLeOQyJ5pwebLxWoXi4tOubCZV+xH?=
 =?iso-8859-1?Q?ayoaf78twykZKTCHEZfvpXf6GTyMw/3BZ7BwO2Li2Q90cAa6C67udR9Mxb?=
 =?iso-8859-1?Q?2jF+P36o4Ts9yoJCXnV3MxZiYR7YDTOp+TTDCSBWhvQbBuIqSfk9bnnfwe?=
 =?iso-8859-1?Q?A7BGiuL+9+nSsTZvsonUIvYE8pNfuKuOyKKSt8din3Vqmk9+FCh8w0G/p5?=
 =?iso-8859-1?Q?bu13dGh+qGQiS7aFMi+QfnAHzJgyjzl1fpfhauFV7NBRxIG05fTXl/7Cyd?=
 =?iso-8859-1?Q?hqvgx+QRz3c8UM5COMgi82PHtyFDJuVcE/qonC9mNycS1DxYUl96pqXWix?=
 =?iso-8859-1?Q?a8MuFoHWth9whaJVCKMWrCJB4cywRBGf1X9a1YsoZcKT+uVhwPbAHbs3oS?=
 =?iso-8859-1?Q?gkeP6ctBm7vZ6xHMh1kDmonZJScENa26nyrUnGHe2YdoiPmuOLczqwxQ1q?=
 =?iso-8859-1?Q?JapfqPaJ4PiqxjeUi58mD7HP+4wVrHpq4ommxfj+9i13e2ny6X7nPuPxpe?=
 =?iso-8859-1?Q?hAHufEupUqklkvIluydMdLfpRQm42HgVW1PwySHX1SvRUUdH8oS7urgbav?=
 =?iso-8859-1?Q?ckGu/k9uXHIxhJOKy6KfUWBWZm/+430tYsQK+slCFkZb9o0bVwr2pQHiOG?=
 =?iso-8859-1?Q?0JBwaxCyT0DEMAKy7LiJ0JxmwP3oNemp/j6VMo6L+AKK7s6T5KYUc9kfWE?=
 =?iso-8859-1?Q?mPpdsFDzIs5HIahpGcG0xEWCl2/ZRRLoxtKFSMbqV8QENDc66YQIjP/uJs?=
 =?iso-8859-1?Q?WaFnaRtCW8qnhIVnLgkS9bsUtOQ3Xy7AZvbgNkjsRrKb7t/gyA/RwEiANM?=
 =?iso-8859-1?Q?TfJUOTAkkL6bZ3YYH7eR?=
MIME-Version: 1.0

--XWDBoundary_HTML_-YYGyxisQvpsttOs
Content-Type: multipart/related;
      boundary="XWDBoundary_HTML_-xpmko_YYGyxisQvpsttOs37503"
Content-Transfer-Encoding: 8bit

--XWDBoundary_HTML_-xpmko_YYGyxisQvpsttOs37503
Content-Type: text/html; charset=iso-8859-1
Content-Transfer-Encoding: 8bit

<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"><meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<!--[if !mso]><style>v:* {behavior:url(#default#VML);}
o:* {behavior:url(#default#VML);}
w:* {behavior:url(#default#VML);}
shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--><div align="CenteR">


<thead>


<thead>

<a clicktracking="off" href="http://internetcampus.org/4zKhTx9392JCmP221trhgqwmsve308QHDLQZETBKOSSOW2801WCSK402962F1" <div="" style="display: block; width: 627px; height: 1234px; max-width: 100% ;  background: url('https://cdn.imgchest.com/files/9df5dfc39d60.png') no-repeat center center; background-size: contain;text-indent: -9999px; margin: 0 auto;"> </div></a><br>
<a clicktracking="off" href="http://internetcampus.org/5Gixlz9392RiRl221ugjlakedis308HJZIMONPGUVKYTW2801ERQZ402962A1" <div="" style="display: block; width: 627px; height: 1234px; max-width: 100% ;  background: url('https://cdn.imgchest.com/files/e43ef51f4728.png') no-repeat center center; background-size: contain;text-indent: -9999px; margin: 0 auto;"> </div></a><br>

<div style="background : transparent url(http://skabeklaterapija.lv/track/3actRO9392TUvF221yjkotexhxy308HKZZHCBIHNVGFLI2801BYEH402962n1) no-repeat center;width:450;height:80px;"></div></a><br>

</head>
<body lang="EN-IN" link="blue" vlink="purple">
<div class="WordSection1"><comment>
<p class="MsoNormal"><span style="color:#1F497D">Hi ROZXOJBLI,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">PuXiOIWnXxxcTwJPhqR1gxShsVROnFoUlH2IwX9PVc2rC.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p>&nbsp;</o:p></span></p>
<div>
<p class="MsoNormal"><span lang="EN-US" style="color:#1F497D"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span style="font-size:13.5pt;color:black"><img width="495" height="58" id="Picture_x0020_1" src="abc"></span><span lang="EN-US" style="font-size:13.5pt;color:black"><br>
</span><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Century Gothic&quot;,&quot;sans-serif&quot;;color:#6D6E71">Aditya Awasthi&nbsp;|&nbsp;&nbsp;Avaya&nbsp;|&nbsp;1st floor&nbsp;|&nbsp;Vipul Plaza&nbsp;<br>
Sun City, Gurgaon&nbsp;|&nbsp;+91 9871997904 |&nbsp;</span><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Century Gothic&quot;,&quot;sans-serif&quot;;color:#ED1B2E"><a href="mailto:cg4george@cytomanix.com">cg4george@cytomanix.com</a></span><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Century Gothic&quot;,&quot;sans-serif&quot;;color:#6D6E71">&nbsp;|&nbsp;</span><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Century Gothic&quot;,&quot;sans-serif&quot;;color:#ED1B2E">cytomanix.com/in</span><span lang="EN-US" style="font-size:13.5pt;color:black">&nbsp;<o:p></o:p></span></p>
</div>
<p class="MsoNormal"><span style="color:#1F497D"><o:p>&nbsp;</o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">From:</span></b><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;"> ROZXOJBLI [mailto:ROZXOJBLIch@cytomanix.com]
<br>
<b>Sent:</b> 24 July 2013 11:56<br>
<b>Cc:</b> Lakshmi N; Swati Nagpal; Nibhakar kumar singh<br>
<b>Subject:</b> Reminder Mail<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p>&nbsp;</o:p></p>
<p class="MsoNormal"><span style="color:black">Dear All,</span><span lang="EN-US" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black">&nbsp;<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black">This is to<strong><span style="font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;">&nbsp;</span></strong><strong><span style="font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;font-weight:normal">remind &nbsp;you that,&nbsp;you all need</span></strong> to&nbsp;&nbsp;send
 your Time Sheets by 24<sup>th</sup> July 2013 <b>(EOD).</b></span><span lang="EN-US" style="color:black">&nbsp;<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span style="color:black">Please note down that the deadline for sending Time Sheets is
<b>24<sup>th</sup> of every month.<o:p></o:p></b></span></p>
<p class="MsoNormal"><b><span style="color:black"><o:p>&nbsp;</o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black">We would await your mail.&nbsp;<o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="EN-US"><o:p>&nbsp;</o:p></span></b></p>
<p class="MsoNormal"><b><span lang="EN-US">Those who had already done, ignore this mail.<o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><b><i><span lang="EN-US" style="font-family:&quot;Segoe Script&quot;,&quot;sans-serif&quot;;color:maroon">Regards,<br>
ROZXOJBLI&nbsp;</span></i></b><b><span lang="EN-GB" style="font-size:24.0pt;font-family:Wingdings;color:maroon;background:white">?</span></b><b><span lang="EN-GB" style="font-size:5.0pt;font-family:Wingdings;color:maroon;background:white"><o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:5.0pt"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><b><i><span lang="EN-US" style="color:maroon">FutureSoft India Private Limited</span></i></b><i><span lang="EN-US" style="color:maroon"><br>
253, IInd Floor, Okhla Industrial Area <o:p></o:p></span></i></p>
<p class="MsoNormal"><i><span lang="EN-US" style="color:maroon">Phase &#8211; III, New Delhi - 110020
<o:p></o:p></span></i></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:maroon">(</span><span lang="EN-US" style="font-size:10.0pt;font-family:Wingdings;color:maroon">(</span><span lang="EN-US" style="font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:maroon">)
</span><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Bookman Old Style&quot;,&quot;serif&quot;;color:maroon">: 91 11</span><span lang="EN-US" style="font-size:10.0pt;font-family:&quot;Bookman Old Style&quot;,&quot;serif&quot;;color:navy">
</span><i><span lang="EN-US" style="color:maroon">42228888<o:p></o:p></span></i></p>
<p class="MsoNormal" style="margin-bottom:12.0pt"><i><span lang="EN-US" style="color:maroon">URL:
</span></i><span lang="EN-US" style="color:maroon"><a href="http://www.cytomanix.com/" originalSrc="http://www.cytomanix.com/"><i><span style="color:maroon">www.futuresoftindiacom</span></i></a></span><span lang="EN-US"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;"><br clear="all">
________________________________________ </span><span lang="EN-US" style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">
‚?oSince young girls began reading about my early life and my career with the chimps, many, many, many of them have told me that they went into conservation or animal behavior because of me," she told CBS News.

Here's what else to know today:
* States with strong gun control laws had three times fewer incidents of domestic violence homicide-suicide, according to a new report released Thursday from Everytown for Gun Safety . The type of violence covered in the new report, shared exclusively with The 19th, is a ‚?oconflation of two public health and public safety crises."

* October has been Domestic Violence Awareness Month  for 38 years. But the progress is now being clawed back, endangering survivors instead, Jasmine Mithani  reports.




‚?oWhen we look at the public discourse on gun violence or on gun violence prevention, it tends to surround very public mass shootings,‚?ù said Sonali Rajan, senior director of research at the gun violence prevention nonprofit that advocates for gun control. The type of violence covered in the new report is a ‚?oconflation of two public health and public safety crises‚?ù ‚?" intimate partner violence and suicide.

Ninety-nine percent of incidents in the report, which looks at data from 2014 to 2020, involved a man shooting a woman. Men make up 87 percent of suicides by firearm in the United States.

‚?oFirearms make it five times more likely that an abuser will kill their female partner,‚?ù Rajan said. Access to a gun also increases the likelihood of death by suicide because of impulsivity and the lethality of firearms.

Nearly 5,500 women were killed by an intimate partner across seven years of data, according to Everytown. In a third of those instances, the abuser then killed themselves and 85 percent of those dual tragedies involved a firearm. The figure is likely underrepresented due to uneven state-by-state data collection. It also doesn‚?Tt include women who were injured by their partner‚?Ts firearm, or threatened with one.

Crucially, this type of lethal violence is preventable. Policy analysis showed that states with strong gun control laws had three times fewer incidents of domestic violence homicide-suicide versus states with the weakest legal codes.
Read the Full Story
Obituary ‚?"


** Jane Goodall, renowned conservationist, dies at 91
------------------------------------------------------------
By J 

Jane Goodall, one of the most renowned woman scientists in the world, died at age 91 in Los Angeles, her namesake institute announced in a statement on Wednesday.

Goodall became famous for her work studying the behaviors of chimpanzees, capturing the attention of institutions like the National Geographic Society, which funded her research and featured an iconic cover image of Goodall observing a group of chimpanzees in the jungle. She would go on to earn a PhD despite never having received a bachelor‚?Ts degree.

It was a childhood dream fulfilled. As she told Time in 2018 : ‚?oWhen I was a little girl, I used to dream as a man, because I wanted to do things that women didn‚?Tt do back then such as traveling to Africa, living with wild animals and writing books.‚?ù

She became a role model for other women and girls who hoped to enter the field. As she told CBS News   ‚?oSince young girls began reading about my early life and my career with the chimps, many, many, many of them have told me that they went into conservation or animal behavior because of me.‚?ù
Read the Full Story :

SUFFS is the Tony Award¬Æ-winning‚?Ømusical  about the brilliant, passionate, and funny American women who fought tirelessly for the right to vote. This ‚?othrilling, inspiring and dazzlingly entertaining‚?ù (Variety) new musical explores the triumphs and failures of a struggle for equality that‚?Ts far from over.
Recommended ‚?"
Recommended reads, listens and streams from some of our favorite publications, including 19th News Network  partners.
Y"- Fact-checking political talking points about the 2025 government shutdown  . PolitiFact is live fact-checking the government s

The 19th
3571 Far West Blvd
#3497
Austin, TX 78731
USA</span><span lang="EN-US" style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">
<o:p></o:p></span></p>
</div>
</body>
</html>

--XWDBoundary_HTML_-xpmko_YYGyxisQvpsttOs37503
Content-Type: image/jpeg;
    name="name=miro-logo_mail-1589550283.jpg"
Content-Transfer-Encoding: base64
Content-ID: <YYGyxisQvpsttOs>


--XWDBoundary_HTML_-xpmko_YYGyxisQvpsttOs37503--

--XWDBoundary_HTML_-YYGyxisQvpsttOs
Content-Type: application/pdf
Content-Transfer-Encoding: base64
Content-Disposition: attachment; filename="AAA-CarKit.pdf"
Content-Description: CVS-Pharmacy


--XWDBoundary_HTML_-YYGyxisQvpsttOs--
